Quinbrook Expands Rowan Green Data Center Platform
Appoints Industry Veterans Bobby Hollis and Dan McNary to Senior Leadership Roles SAN FRANCISCO–(BUSINESS WIRE)–Quinbrook…
Appoints Industry Veterans Bobby Hollis and Dan McNary to Senior Leadership Roles SAN FRANCISCO–(BUSINESS WIRE)–Quinbrook…
The Cambridge-headquartered company earned a place on Built In’s Best Places to Work List for…
Vendr Earns Boston Best Startups to Work For on Built In’s Best Places to Work…
Sensormatic Solutions will be on site at the 2023 NRF Big Show to showcase the…
BOSTON–(BUSINESS WIRE)–Vizit, the leader in image analytics software for global brands and retailers, today announced…
MINNEAPOLIS, Jan. 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company…
Live video webcast on Tuesday, January 17, 2023 at 1:00 PM ET PHILADELPHIA, PA and…
Comprehensive data review suggests a central role for the endocannabinoid system (ECS) in neuronal development,…
Company aims to commercialize wholly-owned KETARX™ (racemic ketamine) for mental health, neurological and pain disorders…
SALT LAKE CITY, Jan. 11, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with…
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
SYDNEY, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing…
DOYLESTOWN, Pa., Jan. 11, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company…
Topline results from SAD and MAD parts of FRTX-02 Phase 1 study expected in Q1…
MELBOURNE, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,”Company”, “GTG”), a…
Innovation Passport provides entry to the U.K.’s Innovative Licensing and Access Pathway (ILAP), which aims…
Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;Active Customer Sites…
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions MORRISVILLE, N.C., Jan. 11,…
RESEARCH TRIANGLE PARK, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Company Remains On-Track to Initiate Phase 2 Proof-of-Concept Clinical Trial in Second Quarter of 2023…